![Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings. - Abstract - Europe PMC Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8924943/bin/10461_2022_3596_Fig2_HTML.jpg)
Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings. - Abstract - Europe PMC
Full article: Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (eto
Clinical development of Ornibel® a new generation etonogestrel/Ethinylestradiol vaginal ring: Comparative bioavailability and t
![Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world - Contraception Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world - Contraception](https://www.contraceptionjournal.org/cms/asset/d14ac193-8f76-4681-a1dc-67f3f37d7619/gr1.jpg)
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world - Contraception
![Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00751/article_deploy/html/images/pharmaceutics-13-00751-g001-550.jpg)
Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings
![Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES - ScienceDirect Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016836591930077X-ga1.jpg)